Enteris BioPharma
Amy Sturmer-Margulis has extensive experience in bioanalytical development, currently serving as Director of Bioanalytical Development at Enteris BioPharma, Inc. since July 2013. Prior to this role, Amy held the position of Director of Bioanalytical Development at Unigene Laboratories from November 1982 to June 2013. Amy's career at Unigene began in 1982, where Amy initially worked as Principal Scientist I until January 1992.
This person is not in any teams
This person is not in any offices
Enteris BioPharma
1 followers
Enteris BioPharma, a clinical stage biopharmaceutical CDMO, specializes in oral peptide drug delivery technology, including its Peptelligence® platform.